CN104673623B - 血液样品收集装置 - Google Patents
血液样品收集装置 Download PDFInfo
- Publication number
- CN104673623B CN104673623B CN201510062267.8A CN201510062267A CN104673623B CN 104673623 B CN104673623 B CN 104673623B CN 201510062267 A CN201510062267 A CN 201510062267A CN 104673623 B CN104673623 B CN 104673623B
- Authority
- CN
- China
- Prior art keywords
- nucleic acid
- blood
- agent
- blood sample
- acid stability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 93
- 239000008280 blood Substances 0.000 title claims abstract description 93
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 88
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 87
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 87
- 239000000654 additive Substances 0.000 claims abstract description 50
- 230000000996 additive effect Effects 0.000 claims abstract description 44
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 44
- 210000002381 plasma Anatomy 0.000 claims abstract description 41
- 239000003146 anticoagulant agent Substances 0.000 claims abstract description 20
- 229940127219 anticoagulant drug Drugs 0.000 claims abstract description 18
- 229920001971 elastomer Polymers 0.000 claims abstract description 14
- 230000001681 protective effect Effects 0.000 claims abstract description 14
- 239000007853 buffer solution Substances 0.000 claims abstract description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000872 buffer Substances 0.000 claims abstract description 8
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims abstract description 6
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229920000669 heparin Polymers 0.000 claims abstract description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims abstract description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 3
- 229960000458 allantoin Drugs 0.000 claims abstract description 3
- 150000003891 oxalate salts Chemical class 0.000 claims abstract description 3
- 239000012528 membrane Substances 0.000 claims description 17
- 239000011521 glass Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000004033 plastic Substances 0.000 claims description 8
- 229920003023 plastic Polymers 0.000 claims description 8
- 229920001707 polybutylene terephthalate Polymers 0.000 claims description 8
- -1 polyethylene terephthalate Polymers 0.000 claims description 8
- 210000004027 cell Anatomy 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 5
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 5
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 5
- CFOAUMXQOCBWNJ-UHFFFAOYSA-N [B].[Si] Chemical compound [B].[Si] CFOAUMXQOCBWNJ-UHFFFAOYSA-N 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical group [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- 229920005549 butyl rubber Polymers 0.000 claims description 4
- 229940009662 edetate Drugs 0.000 claims description 4
- 239000002985 plastic film Substances 0.000 claims description 4
- 229920006255 plastic film Polymers 0.000 claims description 4
- 239000004575 stone Substances 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract description 5
- 239000000463 material Substances 0.000 abstract description 5
- 150000002917 oxazolidines Chemical class 0.000 abstract description 2
- GUPRKDXXJJAUDS-UHFFFAOYSA-M Cl.[OH-].[Na+].NCC(=O)O Chemical compound Cl.[OH-].[Na+].NCC(=O)O GUPRKDXXJJAUDS-UHFFFAOYSA-M 0.000 abstract 1
- CZDSWGSBWBDBQV-UHFFFAOYSA-N acetic acid;pentan-1-amine Chemical compound CC(O)=O.CCCCCN CZDSWGSBWBDBQV-UHFFFAOYSA-N 0.000 abstract 1
- DEQXHPXOGUSHDX-UHFFFAOYSA-N methylaminomethanetriol;hydrochloride Chemical compound Cl.CNC(O)(O)O DEQXHPXOGUSHDX-UHFFFAOYSA-N 0.000 abstract 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 21
- 238000001514 detection method Methods 0.000 description 16
- 238000003860 storage Methods 0.000 description 10
- 238000012360 testing method Methods 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 230000002255 enzymatic effect Effects 0.000 description 5
- 238000005336 cracking Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 229940127090 anticoagulant agent Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- RHYBFKMFHLPQPH-UHFFFAOYSA-N N-methylhydantoin Chemical compound CN1CC(=O)NC1=O RHYBFKMFHLPQPH-UHFFFAOYSA-N 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003322 aneuploid effect Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000009514 concussion Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000010358 mechanical oscillation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000003793 prenatal diagnosis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000020509 sex determination Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
EDTA-K3 | 7.3g |
5,5-二甲基海因 | 16.7g |
N-乙酸甲亚胺 | 11.4g |
血浆DNA浓度 | 实施例(ng/μl) | 实施例(ng/μl) |
第0天 | 2.5 | 2.1 |
第1天 | 2.4 | 2.4 |
第3天 | 2.2 | 2.4 |
第7天 | 2.3 | 2.2 |
第14天 | 2.1 | 2.0 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510062267.8A CN104673623B (zh) | 2015-02-05 | 2015-02-05 | 血液样品收集装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510062267.8A CN104673623B (zh) | 2015-02-05 | 2015-02-05 | 血液样品收集装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104673623A CN104673623A (zh) | 2015-06-03 |
CN104673623B true CN104673623B (zh) | 2018-03-09 |
Family
ID=53309220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510062267.8A Expired - Fee Related CN104673623B (zh) | 2015-02-05 | 2015-02-05 | 血液样品收集装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104673623B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2694285T3 (es) * | 2016-02-11 | 2018-12-19 | Sarstedt Ag & Co. Kg | Dispositivo y procedimiento para el aislamiento de ácidos nucleicos de sangre entera |
CN107760593A (zh) * | 2016-08-19 | 2018-03-06 | 付士明 | 保存和运输循环核酸样本的真空血液采集管 |
CN106244535B (zh) * | 2016-08-30 | 2019-09-20 | 成都瑞琦科技实业股份有限公司 | 孕妇外周血中胎儿游离dna的保存剂及其构成的真空采血管 |
CN106701743A (zh) * | 2016-12-26 | 2017-05-24 | 广州和实生物技术有限公司 | 一种保护和稳定游离dna的采血管 |
CN106701742A (zh) * | 2016-12-26 | 2017-05-24 | 广州和实生物技术有限公司 | 一种保护和稳定游离rna的采血管 |
CN106635770A (zh) * | 2016-12-26 | 2017-05-10 | 广州和实生物技术有限公司 | 一种保护和稳定病毒rna的采血管 |
CN109694901A (zh) * | 2018-06-15 | 2019-04-30 | 麦凯(上海)生物科技有限公司 | 一种用于外周血样中游离dna的保存剂 |
CN112575063A (zh) * | 2020-12-30 | 2021-03-30 | 华南理工大学 | 一种全血基因组dna保存剂及其制备方法与应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101965829A (zh) * | 2010-09-30 | 2011-02-09 | 中国人民解放军第三军医大学野战外科研究所 | 一种冷冻保存红细胞的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN202465673U (zh) * | 2012-03-07 | 2012-10-03 | 天根生化科技(北京)有限公司 | 一种用于核酸纯化的血凝块处理柱装置 |
CN202892421U (zh) * | 2012-07-06 | 2013-04-24 | 付士明 | 游离循环dna采集容器 |
CN103789202B (zh) * | 2014-01-26 | 2017-10-24 | 付士明 | 常温保存核酸的采集容器 |
-
2015
- 2015-02-05 CN CN201510062267.8A patent/CN104673623B/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101965829A (zh) * | 2010-09-30 | 2011-02-09 | 中国人民解放军第三军医大学野战外科研究所 | 一种冷冻保存红细胞的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN104673623A (zh) | 2015-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104673623B (zh) | 血液样品收集装置 | |
CN105985904A (zh) | 循环游离dna真空采集管 | |
Holmes et al. | Biotin interference in clinical immunoassays: a cause for concern | |
CN104381245B (zh) | 一种稳定血液样品细胞的试剂 | |
CN103789202A (zh) | 常温保存核酸的采集容器 | |
CN106244535B (zh) | 孕妇外周血中胎儿游离dna的保存剂及其构成的真空采血管 | |
JP2017523432A (ja) | 全血サンプルの安定化 | |
CN204897890U (zh) | 新型血液样品收集装置 | |
US20190119630A1 (en) | Systems and methods for the digestion of adipose tissue samples obtained from a client for cryopreservation | |
CN107574225A (zh) | 一种血液cfDNA保存剂、真空采血管及其制备方法 | |
EP4116401A1 (en) | Storage container for cell-containing solution and storage solution | |
CN103675279A (zh) | 一种前列腺肿瘤标志物免疫传感器的制备方法及应用 | |
CN108935444A (zh) | 一种rna样本保存液及其应用方法 | |
CN109913416B (zh) | 一种用于冷冻的脐带血造血干细胞复苏后保护剂的配制方法 | |
CN102429665A (zh) | 一种可直接分离血浆的血液采集方法 | |
CN103059623B (zh) | 聚酯防渗膜化剂、防渗膜化聚酯采血管及相应的制备方法 | |
CN204335642U (zh) | 一种用于精子dna完整性检测的精子冻存的冷冻试管 | |
CN204581307U (zh) | 一种真空采血管 | |
CN204016309U (zh) | 新型真空采血管 | |
CN105928753A (zh) | 流式细胞仪校准用鸡红细胞的制备方法 | |
CN202892421U (zh) | 游离循环dna采集容器 | |
CN113373031A (zh) | 一种喷雾型的游离dna样本保存管及应用 | |
CN204495684U (zh) | 一种带刻度的采血、血沉管 | |
CN206295365U (zh) | 一种自带防腐剂的一次性使用24小时尿检留取杯 | |
CN104673659B (zh) | 分离管 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20161221 Address after: 510260 Guangdong, Guangzhou, Xingang West Road, No. 135, a large compound in the park in the park on the middle of the science and Technology Park, No. A, block, No. 1201, room 1202, 1212 Applicant after: GUANGZHO WEIDI MEDICAL TECHNOLOGY CO.,LTD. Address before: 510000 Guangdong, Xingang, No. 135 West Guangzhou Road, science and technology building, block A, floor, building 12 Applicant before: GUANGZHOU SUN-SHING BIOTECH Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180309 |